The role of AMPK as the cell’s primary metabolic hub, which is activated whenever the AMP/ATP ratio is high, has been found to suppress the growth of a number of cancer cells as well as the mammalian target of rapamycin (mTOR) signaling pathway. This evidence concerns the gene MTOR and cancer.